XOLAIR 150 mg/1.2mL
omalizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
XOLAIR is a injection, solution containing omalizumab at 150 mg/1.2mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- XOLAIR
- Generic Name
- omalizumab
- NDC Code (Product)
50242-040- Manufacturer
- Genentech, Inc.
- Strength
- 150 mg/1.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103976
- Drug Class
- Anti-IgE [EPC]
- Marketing Start
- 06/20/2003
Recall History
No Recall HistoryFrequently Asked Questions
What is XOLAIR used for?
XOLAIR contains omalizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is XOLAIR a controlled substance?
XOLAIR is not classified as a controlled substance by the DEA.
What is the generic name for XOLAIR?
The generic name for XOLAIR is omalizumab. There are 3 other brand versions of omalizumab.
What is the NDC code for XOLAIR 150 mg/1.2mL?
The NDC (National Drug Code) for XOLAIR 150 mg/1.2mL is 50242-040, listed by Genentech, Inc..